| 产品详情 |
| Edit |   |
|---|
| Product Name | (R)-Roscovitine |
|---|
| Description | Purity ≥98% (NMR). Potent and selective inhibitor of CDKs. More potent than olomoucine. Inhibits CDK1/cyclin B kinase (IC50 = 450nM), CDK2 (IC50 = 700nM) and CDK5/p35 (IC50 = 160nM). Inhibits M phase promoting factor (MPF) kinase activity. Arrests human fibroblasts in G1 phase. Antitumor compound. Activates the mitogen-activated protein kinase pathway. Targets both the p53 and NF-kappaB pathways. Has effects on calcium channel gating. Prevents DNA damage-induced cyclin A1 upregulation. Apoptosis inducer. As CYC202 in phase I clinical trials. Synonyms: 6-Benzylamino-2-(R)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine |
|---|
| Size | 1mg, 5mg, 50mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 6-Benzylamino-2-(R)--9-isopropylpurine |
|---|
| Gene, Accession, CAS # | CAS: 186692-46-6 |
|---|
| Catalog # | 45188 |
|---|
| Price | |
|---|
| Order / More Info | (R)-Roscovitine from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|